AgricultureTop Companies
Agriculture

Top Chromatography Resins Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

Industry

Agriculture

Published

Feb 2026

Share:

Agriculture

Top Chromatography Resins Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

$3,590

Choose License Type

Only one user can use this report

Additional users can access this report

You can share within your company

Company Contents

Quick Facts & Snapshot

2025 Market Size (US$)
3.90 Billion
2026 Forecast (US$)
4.23 Billion
2032 Forecast (US$)
6.84 Billion
CAGR (2025-2032)
8.40%

Summary

The Chromatography Resins market is in a robust growth phase, underpinned by biopharmaceutical expansion, stricter purity regulations, and advanced therapeutics. Leading Chromatography Resins market companies consolidate share through scale, proprietary chemistries, and global manufacturing networks. From 2025 to 2032, the market is projected to grow from US$ 3.90 Billion to US$ 6.84 Billion, reflecting an 8.40% CAGR.

2025 Revenue of Top Chromatography Resins Suppliers
ReportMines Logo

Source: Secondary Information and ReportMines Research Team - 2026

Ranking Methodology

Rankings of Chromatography Resins market companies are derived from a multi-factor scoring model that blends quantitative and qualitative indicators. Core criteria include estimated 2025 chromatography-resin revenue, 3–5-year growth trajectory, and win rate in major bioprocessing and analytical projects. We also weight installed base across pharma, biotech, food, and environmental labs, as well as breadth of resin modalities, base matrices, and customization capabilities. Technology differentiation, such as high-capacity protein A, single-use compatible formats, and sustainable chemistries, receives additional emphasis. Service coverage, regional manufacturing redundancy, regulatory track record, and ability to support long-term supply and lifecycle management are integrated into a composite competitive-strength score. Strategic moves—acquisitions, licensing deals, process-development partnerships, and investments in continuous and high-throughput chromatography—adjust scores upward or downward. The final ranking reflects overall market power and strategic positioning rather than short-term sales alone.

Top 10 Companies in Chromatography Resins

1
Cytiva (Danaher Corporation)
North America, Europe, Asia Pacific
Marlborough, USA
Global leader in bioprocess chromatography resins with strong biologics and vaccine footprint.
Deep process-development expertise, large installed base, integrated equipment–resin offering.
Biopharmaceuticals, cell and gene therapies, vaccines.
Capacity expansions in Europe and China, partnerships with CDMOs, launches of next-gen high-capacity protein A resins.
Protein A resins, ion-exchange, multimodal and affinity resins for large-scale biopharmaceutical manufacturing.
US$ 1.20 Billion
2
Merck KGaA (MilliporeSigma)
Europe, North America, Asia Pacific
Darmstadt, Germany
Top-tier provider of chromatography resins and integrated bioprocess solutions.
Strong regulatory track record, broad modality portfolio, and high-touch technical services.
Monoclonal antibodies, vaccines, biosimilars, diagnostics.
Investment in continuous bioprocessing resins, sustainability-driven product line extensions, and targeted acquisitions.
Ion-exchange, hydrophobic interaction, affinity resins, and process-scale purification platforms.
US$ 0.95 Billion
3
Sartorius AG
Europe, North America, Asia
Göttingen, Germany
Fast-growing integrated bioprocess player with strengthening resin capabilities.
Integration with upstream and downstream equipment, strong presence in emerging biotechs.
Biologics, cell and gene therapies, contract manufacturing.
New resin manufacturing lines, focus on single-use compatible resins, and strategic collaborations with biotechs.
Chromatography resins, membrane chromatography, and single-use bioprocess solutions.
US$ 0.62 Billion
4
Thermo Fisher Scientific Inc.
North America, Europe, Asia Pacific
Waltham, USA
Diversified life-sciences leader with a solid chromatography resins portfolio.
Extensive distribution network, cross-selling with instruments and consumables.
Analytical labs, pharma QC, biotech R&D.
Portfolio rationalization, expansion in analytical-grade resins, and integration with chromatography instruments.
Analytical and process resins, specialty affinity resins, and OEM solutions.
US$ 0.45 Billion
5
Bio-Rad Laboratories, Inc.
North America, Europe, Asia
Hercules, USA
Established chromatography player with strong legacy in research and process resins.
Broad catalog, strong academic and research relationships.
Research institutions, biopharma, diagnostics.
R&D on high-resolution resins, focus on biopharma and advanced therapy customers.
Ion-exchange, size exclusion, mixed-mode resins for research and process-scale applications.
US$ 0.30 Billion
6
Tosoh Corporation
Asia Pacific, North America, Europe
Tokyo, Japan
Key Asia-based supplier of high-performance chromatography resins.
Strong polymer science competencies and high-performance products for demanding separations.
Biopharma, food and beverage, industrial separations.
Capacity upgrades in Japan, targeted expansion into biologics manufacturing hubs.
HPLC-grade resins, process-scale resins, and specialty polymer chemistries.
US$ 0.26 Billion
7
Repligen Corporation
North America, Europe
Waltham, USA
Specialized bioprocess technology firm with differentiated chromatography solutions.
Innovation in ready-to-use formats and custom solutions for CDMOs and biotechs.
CDMOs, emerging biotech, biosimilar manufacturers.
Partnerships for novel ligands, expansion of pre-packed column capabilities.
Affinity ligands, OPUS pre-packed columns, and custom resin development.
US$ 0.18 Billion
8
Bio-Works Technologies AB
Europe, North America, Asia
Uppsala, Sweden
Niche provider focused on innovative agarose-based chromatography resins.
High-performance agarose matrices with flexible customization options.
Small and mid-size biopharma, academic manufacturing centers.
Channel partnerships, focus on mid-sized biopharma and regional CDMOs.
WorkBeads resins for pilot and small-scale manufacturing, with growing process-scale adoption.
US$ 0.06 Billion
9
Purolite, an Ecolab Company
North America, Europe, Asia
King of Prussia, USA
Specialty resin supplier leveraging cross-sector ion-exchange expertise.
Strong manufacturing scale and experience in critical-process industries.
Bioprocessing, water treatment for pharma, industrial biotech.
Integration with Ecolab life-sciences portfolio, expansion of bioprocessing-grade capacity.
Ion-exchange and specialty resins for bioprocessing and industrial applications.
US$ 0.09 Billion
10
Mitsubishi Chemical Group Corporation
Asia, North America, Europe
Tokyo, Japan
Diversified chemical group with niche chromatography resin offerings.
Integration with broader specialty-chemicals platform and materials science capabilities.
Industrial separations, specialty chemicals, select biopharma processes.
Portfolio optimization, focus on high-value separation niches and OEM partnerships.
Industrial chromatography resins and selected bioprocessing applications.
US$ 0.05 Billion

Source: Secondary Information and ReportMines Research Team - 2026

Detailed Company Profiles

1

Cytiva (Danaher Corporation)

Cytiva is a global bioprocess leader providing chromatography resins, equipment, and services across the full biologics development and manufacturing lifecycle.

Key Financials: 2025 Chromatography Resins revenue US$ 1.20 Billion; segment growth 9.50% CAGR.
Flagship Products: MabSelect PrismA, Capto ion-exchange resins, Sepharose Fast Flow.
2025-2026 Actions: Expanded resin manufacturing in Europe and China, launched high-capacity protein A, deepened alliances with major CDMOs.
Three-line SWOT: Dominant installed base and strong brand equity; High exposure to biopharma capital cycles; Opportunity—surging demand for monoclonal antibodies and continuous bioprocessing.
Notable Customers: Pfizer, Lonza, Samsung Biologics.
2

Merck KGaA (MilliporeSigma)

Merck’s Life Science business offers a broad chromatography resin portfolio integrated with filtration, single-use, and process automation solutions.

Key Financials: 2025 Chromatography Resins revenue US$ 0.95 Billion; R&D intensity 7.80% of sales.
Flagship Products: Eshmuno A, Fractogel ion-exchange resins, ProSep affinity resins.
2025-2026 Actions: Invested in sustainable resin chemistries, expanded continuous bioprocessing solutions, completed tuck-in acquisitions in purification technologies.
Three-line SWOT: Comprehensive bioprocess portfolio; Complex legacy product set; Opportunity—growth in biosimilars and emerging-market biologics manufacturing.
Notable Customers: Roche, Biocon, FUJIFILM Diosynth Biotechnologies.
3

Sartorius AG

Sartorius delivers integrated upstream and downstream bioprocess solutions, increasingly anchored by proprietary chromatography resins and membrane technologies.

Key Financials: 2025 Chromatography Resins revenue US$ 0.62 Billion; operating margin 18.40%.
Flagship Products: Sartobind membrane chromatography, Sartobind Q, novel resin lines for mAb purification.
2025-2026 Actions: Scaled resin production, accelerated single-use compatible resin development, pursued technology partnerships with novel therapy developers.
Three-line SWOT: Strong integration with single-use platforms; Limited legacy in some resin modalities; Opportunity—adoption of flexible, small-footprint bioprocessing suites.
Notable Customers: Novartis, WuXi Biologics, Catalent.
4

Thermo Fisher Scientific Inc.

Thermo Fisher combines analytical instrumentation, consumables, and chromatography resins to support end-to-end workflows in labs and manufacturing.

Key Financials: 2025 Chromatography Resins revenue US$ 0.45 Billion; segment growth 7.60% CAGR.
Flagship Products: POROS resins, CaptureSelect affinity resins, Toyopearl-branded OEM resins.
2025-2026 Actions: Aligned resins tightly with chromatography systems, expanded analytical-grade offerings, targeted high-growth biotech clusters.
Three-line SWOT: Extensive channel and instrumentation synergy; Less focus on very-large-scale mAb resins; Opportunity—growth in analytical and QC chromatography volumes.
Notable Customers: Regeneron, GSK, large contract testing labs.
5

Bio-Rad Laboratories, Inc.

Bio-Rad serves research and biopharma production with chromatography resins and systems known for reliability and robust separation performance.

Key Financials: 2025 Chromatography Resins revenue US$ 0.30 Billion; R&D spend 9.20% of sales.
Flagship Products: Nuvia ion-exchange resins, UNOsphere media, Bio-Scale columns.
2025-2026 Actions: Focused on higher-resolution resins, expanded biopharma technical-support teams, refreshed legacy product lines.
Three-line SWOT: Strong research presence and diverse catalog; Smaller scale in mega-mAb plants; Opportunity—translation of research relationships into process-scale contracts.
Notable Customers: Academic GMP centers, Amgen, regional biopharma manufacturers.
6

Tosoh Corporation

Tosoh leverages advanced polymer chemistry to supply high-performance chromatography resins for both analytical and process applications.

Key Financials: 2025 Chromatography Resins revenue US$ 0.26 Billion; operating margin 16.10%.
Flagship Products: TOYOPEARL resins, TSKgel resins, specialty polymeric media.
2025-2026 Actions: Expanded capacity in Japan, focused on biologics hubs, and broadened application-development support.
Three-line SWOT: Strong performance in demanding separations; Concentrated manufacturing footprint; Opportunity—rising biologics capacity in Asia Pacific.
Notable Customers: Japanese big pharma, Asian CDMOs, specialty chemical producers.
7

Repligen Corporation

Repligen is an innovation-focused bioprocess supplier specializing in chromatography ligands, pre-packed columns, and high-performance purification solutions.

Key Financials: 2025 Chromatography Resins revenue US$ 0.18 Billion; revenue growth 11.30% CAGR.
Flagship Products: OPUS pre-packed columns, affinity ligands, custom resin solutions.
2025-2026 Actions: Enhanced ligand-development partnerships, scaled pre-packed offerings, targeted advanced therapies and agile CDMOs.
Three-line SWOT: Strong differentiation in pre-packed formats; Smaller manufacturing scale versus top-tier giants; Opportunity—outsourcing trend to CDMOs and flexible facilities.
Notable Customers: Thermo Fisher CDMO units, mid-size biotechs, global CDMOs.
8

Bio-Works Technologies AB

Bio-Works is a specialized Swedish firm offering agarose-based chromatography resins aimed at agile, high-performance purification workflows.

Key Financials: 2025 Chromatography Resins revenue US$ 0.06 Billion; revenue growth 13.20% CAGR.
Flagship Products: WorkBeads 40, WorkBeads affimAb, WorkBeads custom resins.
2025-2026 Actions: Expanded distribution, targeted mid-tier biopharma, and invested in process-scale validation studies.
Three-line SWOT: Flexible, customer-centric innovation; Limited global scale and brand recognition; Opportunity—growing mid-market biologics manufacturers seeking alternatives to tier-1 suppliers.
Notable Customers: Regional CDMOs, European biotechs, academic production sites.
9

Purolite, an Ecolab Company

Purolite applies extensive ion-exchange expertise to bioprocess-grade chromatography resins used in purification and process water conditioning.

Key Financials: 2025 Chromatography Resins revenue US$ 0.09 Billion; R&D spend 6.70% of sales.
Flagship Products: Praesto protein A resins, ion-exchange resins, custom-engineered media.
2025-2026 Actions: Deepened integration with Ecolab life-sciences, expanded cGMP manufacturing capabilities, broadened bioprocess offering.
Three-line SWOT: Strong core in resin chemistry and scale; Less established in some advanced modalities; Opportunity—bioprocess-water, hybrid purification, and specialized resins.
Notable Customers: Large pharma utilities, biopharma manufacturers, industrial biotech firms.
10

Mitsubishi Chemical Group Corporation

Mitsubishi Chemical offers specialized chromatography resins within a broader portfolio of performance materials and chemical solutions.

Key Financials: 2025 Chromatography Resins revenue US$ 0.05 Billion; segment growth 5.40% CAGR.
Flagship Products: Diaion resins, industrial chromatography media, specialty separation resins.
2025-2026 Actions: Focused on high-value niche separations, leveraged OEM and technology alliances, optimized product mix.
Three-line SWOT: Diverse materials-science base and industrial relationships; Limited visibility in mainstream biopharma resins; Opportunity—industrial biotech and high-purity chemical separations.
Notable Customers: Chemical producers, industrial biotech firms, selected pharma manufacturers.

SWOT Leaders

Cytiva (Danaher Corporation)

SWOT Snapshot

SWOT
Strengths

Largest installed base, deep bioprocess know-how, broad portfolio from lab to commercial scale, strong global service network.

Weaknesses

High pricing relative to regional competitors, dependence on large biopharma capex cycles, complex product ecosystem.

Opportunities

Expanding monoclonal antibody pipeline, growth of biosimilars in emerging markets, continuous and intensified processing adoption.

Threats

Intensifying competition from Merck and Sartorius, regulatory pressures on cost, potential supply-chain disruptions for critical inputs.

Merck KGaA (MilliporeSigma)

SWOT Snapshot

SWOT
Strengths

Comprehensive end-to-end bioprocess portfolio, strong regulatory track record, global manufacturing spread, robust technical support.

Weaknesses

Complex legacy product lines, integration challenges across platforms, higher cost base than some Asian vendors.

Opportunities

Biosimilar expansion, sustainable resin demand, increasing outsourcing to CDMOs needing integrated solutions.

Threats

Price competition in commodity resins, macroeconomic pressure on biopharma investments, evolving regulatory expectations for sustainability.

Sartorius AG

SWOT Snapshot

SWOT
Strengths

Strong brand in single-use bioprocessing, growing chromatography resin capability, agile innovation pipeline, close ties to emerging biotechs.

Weaknesses

Smaller resin footprint versus market leaders, exposure to biotech funding cycles, capacity constraints in rapid upswings.

Opportunities

Rise of flexible, modular facilities, single-use adoption in emerging markets, advanced therapy manufacturing growth.

Threats

Competition from integrated giants, technology disruption from novel separation modalities, currency and cost volatility in Europe.

Chromatography Resins Market Regional Competitive Landscape

North America remains the largest regional market, driven by mature biopharmaceutical clusters in the United States and Canada. Cytiva, Merck KGaA (MilliporeSigma), Sartorius, and Thermo Fisher dominate, supported by strong CDMO demand and continued investment in monoclonal antibodies, cell and gene therapies, and vaccine manufacturing capacity expansions.

Europe hosts a dense network of innovator and biosimilar manufacturers, with Germany, Switzerland, France, and the Nordics as key hubs. Merck KGaA, Sartorius, Cytiva, and Bio-Rad are particularly prominent. Regulatory emphasis on quality and sustainability encourages adoption of high-performance resins and greener chemistries, benefiting technologically advanced Chromatography Resins market companies.

Asia Pacific is the fastest-growing region, underpinned by capacity build-out in China, South Korea, India, and Singapore. Cytiva and Merck lead large strategic projects, while Tosoh and Mitsubishi Chemical provide strong local competition. Government-backed biologics parks and incentives for domestic biosimilar production create significant opportunities for both global and regional Chromatography Resins market companies.

Latin America shows steady but more modest growth, constrained by funding cycles and regulatory complexity. Brazil and Mexico are primary demand centers, often served via distributors. Global suppliers like Cytiva, Merck, and Thermo Fisher compete with cost-sensitive offerings, while mid-tier Chromatography Resins market companies target niche applications and pilot-scale facilities.

Middle East and Africa remain nascent but strategically important, with emerging vaccine and biopharma initiatives in Gulf Cooperation Council countries and South Africa. Projects often rely on technology transfer from multinational players. Chromatography Resins market companies that can bundle training, turnkey skids, and robust supply chains gain a competitive advantage in early-stage tenders.

In Eastern Europe and Russia-adjacent markets, growth is mixed due to geopolitical risk and investment uncertainty. Nevertheless, localized manufacturing incentives and generic-biologics initiatives continue. Global Chromatography Resins market companies cautiously expand via partnerships, while regional distributors and engineering firms play critical roles in system integration and lifecycle support.

Chromatography Resins Market Emerging Challengers & Disruptive Start-Ups

Emerging Challengers & Disruptive Start-Ups

NanoPoreX Bioseparations
Disruptor
USA

Develops nanoporous polymer chromatography resins that combine ultra-high binding capacity with reduced buffer consumption for intensified bioprocessing.

GreenMatrix Ligands
Disruptor
Germany

Focuses on bio-based, recyclable ligand chemistries designed to reduce solvent use and environmental impact in large-scale purification processes.

AgaroNext Biotech
Disruptor
India

Produces cost-competitive agarose resins optimized for regional biosimilar manufacturers, with strong customization and technical support capabilities.

FlowPeak Continuous
Disruptor
Sweden

Offers resin–column packages specifically engineered for continuous chromatography, enabling higher productivity in compact manufacturing footprints.

LigandAI Analytics
Disruptor
United Kingdom

Applies AI-driven design to create novel affinity ligands and resin formulations, shortening development timelines for Chromatography Resins market companies.

BioSeps Middle East
Disruptor
United Arab Emirates

Targets regional vaccine and biologics plants with modular resin solutions and on-site service, closing logistical gaps left by global incumbents.

Chromatography Resins Market Future Outlook & Key Success Factors (2026-2032)

From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Chromatography Resins market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.

Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Chromatography Resinsmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.

Frequently Asked Questions

Find answers to common questions about this company report.